Cargando…

Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers

Epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 3 (HER3) have been investigated as triple-negative breast cancer (TNBC) biomarkers. Reduced EGFR levels can be compensated by increases in HER3; thus, assaying EGFR and HER3 together may improve prognostic value. In a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogden, Angela, Bhattarai, Shristi, Sahoo, Bikram, Mongan, Nigel P., Alsaleem, Mansour, Green, Andrew R., Aleskandarany, Mohammed, Ellis, Ian O., Pattni, Sonal, Li, Xiaoxian (Bill), Moreno, Carlos S., Krishnamurti, Uma, Janssen, Emiel A., Jonsdottir, Kristin, Rakha, Emad, Rida, Padmashree, Aneja, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033213/ https://www.ncbi.nlm.nih.gov/pubmed/32080212 http://dx.doi.org/10.1038/s41598-020-59514-1

Ejemplares similares

Machine learning-based prediction of breast cancer growth rate in vivo
por: Bhattarai, Shristi, et al.
Publicado: (2019)

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
por: Klimov, Sergey, et al.
Publicado: (2017)

Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer
por: Ogden, Angela, et al.
Publicado: (2017)

Panoptic Overview of Triple-Negative Breast Cancer in Nigeria: Current Challenges and Promising Global Initiatives
por: Wright, Nikita, et al.
Publicado: (2018)

A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk
por: Klimov, Sergey, et al.
Publicado: (2019)

Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors
por: Ogden, Angela, et al.
Publicado: (2017)

Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells
por: Mittal, Karuna, et al.
Publicado: (2017)

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
por: Bhattarai, Shristi, et al.
Publicado: (2019)

Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
por: Atallah, N. M., et al.
Publicado: (2023)

Panoptic View of Prognostic Models for Personalized Breast Cancer Management
por: Saini, Geetanjali, et al.
Publicado: (2019)

Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4
por: Mittal, Karuna, et al.
Publicado: (2022)

Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations
por: Wright, Nikita, et al.
Publicado: (2017)

Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer
por: Kariri, Yousif A., et al.
Publicado: (2019)

The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers
por: Mahathre, Monica M., et al.
Publicado: (2016)

A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients
por: Xu, Qi, et al.
Publicado: (2022)

The characteristics and clinical significance of atypical mitosis in breast cancer
por: Lashen, Ayat, et al.
Publicado: (2022)

KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries
por: Pawar, Shrikant, et al.
Publicado: (2014)

PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer
por: Garlapati, Chakravarthy, et al.
Publicado: (2023)

Quadruple-negative breast cancer: novel implications for a new disease
por: Bhattarai, Shristi, et al.
Publicado: (2020)

Quadruple-Negative Breast Cancer: An Uneven Playing Field
por: Saini, Geetanjali, et al.
Publicado: (2020)

Predicting Metastasis Risk in Pancreatic Neuroendocrine Tumors Using Deep Learning Image Analysis
por: Klimov, Sergey, et al.
Publicado: (2021)

Protein Conformational Changes in Breast Cancer Sera Using Infrared Spectroscopic Analysis
por: Ghimire, Hemendra, et al.
Publicado: (2020)

Hypoxia-Induced Centrosome Amplification Underlies Aggressive Disease Course in HPV-Negative Oropharyngeal Squamous Cell Carcinomas
por: Mittal, Karuna, et al.
Publicado: (2020)

Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer
por: Kariri, Yousif, et al.
Publicado: (2022)

Refining the definition of HER2‐low class in invasive breast cancer
por: Atallah, Nehal M, et al.
Publicado: (2022)

Prevalence and Mortality of Triple-Negative Breast Cancer in West Africa: Biologic and Sociocultural Factors
por: Nwagu, Gift C., et al.
Publicado: (2021)

Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer
por: Joseph, Chitra, et al.
Publicado: (2019)

A key genomic subtype associated with lymphovascular invasion in invasive breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2019)

SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis
por: Seth, Gaurav, et al.
Publicado: (2020)

Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers
por: Pannu, Vaishali, et al.
Publicado: (2015)

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer
por: Fisher, Timothy B., et al.
Publicado: (2023)

Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer
por: Kariri, Yousif A., et al.
Publicado: (2022)

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2012)

QNBC Is Associated with High Genomic Instability Characterized by Copy Number Alterations and miRNA Deregulation
por: Bhattarai, Shristi, et al.
Publicado: (2021)

Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival
por: Joseph, Chitra, et al.
Publicado: (2020)

HSET overexpression fuels tumor progression via centrosome clustering-independent mechanisms in breast cancer patients
por: Pannu, Vaishali, et al.
Publicado: (2015)

Deep learning based registration of serial whole-slide histopathology images in different stains
por: Roy, Mousumi, et al.
Publicado: (2023)

Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer
por: Mittal, Karuna, et al.
Publicado: (2017)

The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma
por: Joseph, Chitra, et al.
Publicado: (2020)

Exosomal Metabolic Signatures Are Associated with Differential Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
por: Joshi, Shriya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uj4vk7fp3lrlj093fb25v7d63n